恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01276 恒瑞医药

休市中 04-24 16:08:27

68.850

+0.150

+0.22%

最高70.100	最低67.350	成交量173.77万
今开70.100	昨收68.700	日振幅4.00%
总市值4,570亿	流通市值177.63亿	总股本66.37亿
成交额1.19亿	换手率0.67%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":68.85,"timestamp":1777018107004,"preClose":68.7,"halted":0,"volume":1737673,"delay":0,"changeRate":0.0021834061135369938,"floatShares":258000000,"shares":6637000000,"eps":1.352488991271371,"marketStatus":"休市中","change":0.15,"latestTime":"04-24 16:08:27","open":70.1,"high":70.1,"low":67.35,"amount":119436742,"amplitude":0.040029,"askPrice":68.95,"askSize":7400,"bidPrice":68.85,"bidSize":5400,"shortable":3,"etf":0,"ttmEps":1.3991590308871231,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":68.7,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0.6456902691249171,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":56.05,"timestamp":1777014000000,"preClose":56.4,"halted":0,"volume":55779700,"delay":0,"premium":"+7.17"}},"requestUrl":"/m/hq/s/01276","defaultTab":"news","newsList":[{"id":"2630879944","title":"花旗：恒瑞医药给予“买入”评级 目标价134港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630879944","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630879944?lang=zh_cn&edition=full","pubTime":"2026-04-25 10:15","pubTimestamp":1777083300,"startTime":"0","endTime":"0","summary":"　　花旗发布研报称，给予恒瑞医药H股目标价134港元以及“买入”评级。花旗指出，恒瑞医药2026年第一季创新药销售年增26%至45亿元人民币，占产品销售比重由去年同期的54%提升至62%。　　公司管理层重申2026年创新药销售年增超过30%的目标，并指出3月医院准入加速，为全年销售增长奠定基础。公司2026年第一季确认来自葛兰素史克合作的BD收入7.87亿元人民币，全年预计约2.5亿元人民币。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-04-25/doc-inhvsqpe7283823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01276","600276","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629950788","title":"瑞银：升恒瑞医药(01276)目标价至97.4港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629950788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629950788?lang=zh_cn&edition=full","pubTime":"2026-04-24 10:54","pubTimestamp":1776999295,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，基于2026年第一季业绩，由于研发进展，上调恒瑞医药(01276)长期销售预测。目标价由91港元升至97.4港元，维持“买入”评级。恒瑞医药首季营收同比增13%至81.4亿元人民币，略低于市场预测85.3亿元人民币及该行预测88.1亿元人民币;净利润增长21.8%至22.8亿元人民币，大致符合市场预测21.8亿元人民币及该行预测23.3亿元人民币。第一季毛利率同比增1.4个百分点至86.6%; 净利润率上升2个百分点至28%。第一季研发投资达22.2亿人民币，其中16.5亿元人民币计入费用;销售费用率下降0.3个百分点至27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01276","EWH","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629864397","title":"T3出行、明珠化工、圆心科技递表港交所主板；平安好医生、中国电信、恒瑞医药发布一季度报告丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2629864397","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629864397?lang=zh_cn&edition=full","pubTime":"2026-04-24 07:00","pubTimestamp":1776985211,"startTime":"0","endTime":"0","summary":"｜2026年4月24日星期五｜NO.1T3出行、明珠化工、圆心科技递表港交所主板据港交所4月22日消息，南京领行科技股份有限公司（以下简称T3出行）、湖南明珠矿用化工科技股份有限公司（以下简称明珠化工）、北京圆心科技集团股份有限公司（以下简称圆心科技）已向港交所主板提交上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604243716838768.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243716838768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1506","BK1219","BK1589","LU1580142542.USD","HK0000352382.USD","LU2097828805.USD","HK0000288784.HKD","LU2543165471.USD","LU2580892789.USD","LU1064130708.USD","BK1610","LU1146622755.USD","LU2580892862.HKD","BK1142","BK0239","LU1997245177.USD","LU1328615791.USD","LU1781817850.SGD","LU0039217434.USD","LU0359201885.HKD","LU2328871848.SGD","HK0000352291.HKD","BK1191","BK0028","01833","00728","LU2488822045.USD","BK1617","IPOS","LU2097828631.EUR","BK0261","LU2097828474.EUR","SGXZ49509284.SGD","LU2148510915.USD","BK1615","LU1997245094.SGD","BK1536","LU2289578879.USD","LU1255011170.USD","BK1247","BK0060","LU1655091616.SGD","LU1820825898.SGD","LU2097828557.USD","LU2495084118.USD","LU0405327494.USD","LU1969619763.USD","01276","600276","601728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629836502","title":"恒瑞医药：二级市场波动受多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2629836502","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629836502?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:19","pubTimestamp":1776943140,"startTime":"0","endTime":"0","summary":"证券日报网讯4月23日，恒瑞医药在互动平台回答投资者提问时表示，二级市场波动受多重因素影响。公司目前经营稳定，严守合规底线，高标准、严要求、全方位打造合规文化，不断巩固合规意识，确保全面高质量合规，推动公司业务可持续发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233716339814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","LU2097828557.USD","LU2488822045.USD","BK0196","01276","LU2148510915.USD","LU2495084118.USD","LU0359201612.USD","BK0012","LU2543165471.USD","LU0359202008.SGD","LU2580892862.HKD","LU2097828474.EUR","LU1146622755.USD","BK1191","LU1064130708.USD","LU1255011170.USD","LU1064131003.USD","LU1580142542.USD","LU2328871848.SGD","LU2097828714.EUR","LU1997245177.USD","LU1997244956.HKD","BK0183","LU2097828631.EUR","LU0405327148.USD","LU1781817850.SGD","LU2097828805.USD","LU0405327494.USD","LU1328615791.USD","LU2289578879.USD","LU1820825898.SGD","LU1969619763.USD","LU1997245094.SGD","LU2580892789.USD","BK0239","600276","LU1655091616.SGD","BK0060","LU1023057109.AUD","BK0188","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629854198","title":"智通AH统计|4月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2629854198","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629854198?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:15","pubTimestamp":1776932108,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月23日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为558.54%、345.30%、303.33%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-25.17%、-19.16%、-6.60%。其中华勤技术、龙源电力、东北电气的偏离值位居前三，分别为41.36%、27.55%、25.00%；另外，剑桥科技、长城汽车、中金公司的偏离值位居后三，分别为-35.74%、-21.79%、-19.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02338","02359","601633","00187","01349","03750","82333","LU0061477393.USD","00042","02009","00916","IE00B031J352.USD","01057","02603","06031","399300","00956","09611","159982","BK1516","01276","03678","00300","00317","02899","03296","EWH","02701","06166","03968","01033","00553","02218","06613","LU0231483743.USD","00470","00895","03143","LU0348767384.USD","LU0456827905.SGD","03986","GWLLY","03908","01812","01108","03328","03969","02333","02208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629607068","title":"港股异动 | 恒瑞医药(01276)绩后涨超5% 一季度归母净利同比增加21.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629607068","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629607068?lang=zh_cn&edition=full","pubTime":"2026-04-23 09:36","pubTimestamp":1776908175,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，恒瑞医药绩后涨超5%，截至发稿，涨3.22%，报68.85港元，成交额1.35亿港元。消息面上，4月22日，恒瑞医药发布公告，于2026年第一季度，该集团取得营业收入人民币81.41亿元，同比增加12.98%；归属于上市公司股东的净利润22.82亿元，同比增加21.78%；基本每股收益0.34元。2026年第一季度，公司创新药销售收入45.26亿元，同比增长 25.75%，占药品销售收入的比重达61.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2289578879.USD","LU0359201612.USD","LU1146622755.USD","LU1655091616.SGD","LU0405327148.USD","LU2097828805.USD","LU1997245094.SGD","LU1781817850.SGD","LU2097828631.EUR","LU2097828557.USD","LU2097828474.EUR","LU1328615791.USD","LU1580142542.USD","LU1969619763.USD","BK0188","LU0405327494.USD","LU1997244956.HKD","BK0196","BK0060","LU2543165471.USD","VXUS","LU1064131003.USD","BK0028","LU2097828714.EUR","LU2328871848.SGD","600276","LU2488822045.USD","BK0012","LU1820825898.SGD","BK1191","LU1023057109.AUD","LU2580892862.HKD","BK4588","LU0359202008.SGD","BK0239","LU1255011170.USD","LU2580892789.USD","LU0359201885.HKD","01276","LU1064130708.USD","BK0183","LU2148510915.USD","LU2495084118.USD","LU1997245177.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100109576","title":"异动解读 | 一季度业绩亮眼，创新药收入大增，恒瑞医药盘中大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100109576","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100109576?lang=zh_cn&edition=full","pubTime":"2026-04-23 09:35","pubTimestamp":1776908115,"startTime":"0","endTime":"0","summary":"恒瑞医药今日盘中股价大幅拉升，涨幅一度达到5.31%，表现强势。报告显示，公司第一季度实现营业收入81.41亿元，同比增长12.98%；归属于上市公司股东的净利润为22.82亿元，同比大幅增长21.78%。尤为亮眼的是，创新药销售收入达到45.26亿元，同比增长25.75%，占药品销售收入的比重提升至61.69%，收入结构持续优化。第一季度，公司创新药对外许可业务确认收入7.87亿元，成为新的增长引擎。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629608077","title":"港股公告掘金 | 恒瑞医药一季度归母净利润同比增加21.78% 赛力斯拟回购最多20亿元A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629608077","media":"智通财经","labels":["shareholding","dataReport","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629608077?lang=zh_cn&edition=full","pubTime":"2026-04-23 09:03","pubTimestamp":1776906229,"startTime":"0","endTime":"0","summary":"【重大事项】华勤技术(03296)：香港公开发售获531.33倍认购 每股发售价77.7港元赛力斯(09927)拟回购10亿-20亿元的A股 助力价值回归博泰车联(02889)与地平线签署战略合作协议 共同打造汽车智能化、国产化的平台级解决方案康耐特光学(02276)与一家在智能眼镜领域占据行业领导地位的全球领先科技企业签署合作备忘录达力普控股(01921)附属拟引入库卡AI智能机器人技术 积极推","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1119","BK1191","LU2488822045.USD","BK0239","LU1255011170.USD","600276","LU1820825898.SGD","SG9999002950.SGD","LU0405327148.USD","LU1064130708.USD","LU0307460666.USD","LU2580892862.HKD","BK0201","LU1655091616.SGD","BK1556","LU2543165471.USD","LU2289578879.USD","LU1880383366.USD","LU1997245177.USD","SG9999001069.SGD","LU0871576103.HKD","BK0028","BK0014","SG9999001051.SGD","LU2148510915.USD","LU2495084118.USD","SG9999006597.SGD","BK0188","601127","BK1588","BK0012","LU0650527681.SGD","BK0185","BK1596","BK0060","LU1781817850.SGD","LU0039217434.USD","LU0405327494.USD","LU2517655291.USD","BK1193","LU2580892789.USD","BK0264","LU2097828557.USD","BK4588","LU1880383440.USD","LU2097828805.USD","BK1519","BK0183","LU0164865239.USD","LU0359201612.USD","LU2517655374.HKD","SG9999001093.SGD","BK1109","BK4585","LU1969619763.USD","LU0359201885.HKD","01276","IE0034224299.USD","LU1997244956.HKD","LU1023057109.AUD","BK1228","LU0594300179.USD","BK0196","LU1328615791.USD","LU0531971595.HKD","LU2097828714.EUR","LU0605514214.HKD","LU2517655028.SGD","LU0359202008.SGD","LU2328871848.SGD","LU2097828474.EUR","LU0588546209.SGD","09927","LU1064131003.USD","BK1095","LU0594300419.USD","LU2097828631.EUR","LU1997245094.SGD","LU1146622755.USD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629071540","title":"智通港股早知道 | 中办、国办：持续推进绿色交通基础设施建设 恒瑞医药(01276)一季度归母净利润同比增加21.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629071540","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629071540?lang=zh_cn&edition=full","pubTime":"2026-04-23 07:22","pubTimestamp":1776900146,"startTime":"0","endTime":"0","summary":"恒瑞医药发布第一季度业绩，归母净利润22.82亿元 同比增加21.78%恒瑞医药发布公告，于2026年第一季度，该集团取得营业收入人民币81.41亿元，同比增加12.98%；归属于上市公司股东的净利润22.82亿元，同比增加21.78%；基本每股收益0.34元。经营利润同比上升44.8%至1.803亿美元。截至2026年2月28日止首九个月，净营收为41.318亿美元，同比增加13.0%。经营利润为5.575亿美元，同比增加27.6%。新东方股东应占净利润为4.13亿美元，同比增加13.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600276","01276","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629127880","title":"创新药收入占比首破六成，恒瑞医药Q1营收81亿元，净利同增22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629127880","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629127880?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:22","pubTimestamp":1776853336,"startTime":"0","endTime":"0","summary":"恒瑞医药一季报显示，公司实现营收81.41亿元，同比增长12.98%；归母净利润22.82亿元，同比增长21.78%。创新药销售收入占比首次突破六成，达61.69%，其中非肿瘤产品收入同比增长92.13%，多元化趋势明显。报告期内累计研发投入22.24亿元，3项创新成果获批，8项新药上市申请获受理，管线推进节奏加快。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770612","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创新药收入占比首破六成，恒瑞医药Q1营收81亿元，净利同增22%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","600276","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180885491","title":"恒瑞医药2026年第一季度营收81.41亿元，经调整净利润22.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180885491","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180885491?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:56","pubTimestamp":1776851767,"startTime":"0","endTime":"0","summary":"恒瑞医药2026年第一季度实现营收81.41亿元，同比增长12.98%。经调整净利润22.82亿元，同比提升21.78%。毛利率约为86.58%，经营利润率约为32.04%。经营活动现金流达7.86亿元，同比增加41.66%。销售及管理费用合计约28.14亿元，占营收比重约34.58%。同期，研发投入保持在较高水平，费用化研发为16.51亿元，同比上升约7.70%，体现了持续发力创新的战略导向。其中，抗肿瘤创新药收入33.13亿元，同比增长11.63%；非肿瘤创新药收入12.13亿元，同比增长92.13%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"恒瑞医药2026年第一季度营收81.41亿元，经调整净利润22.82亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019821","title":"恒瑞医药：第一季度净利润22.82亿元，同比增长21.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019821","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629019821?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:12","pubTimestamp":1776849143,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月22日，恒瑞医药（HK1276）公告，2026年第一季度营业收入81.41亿元，同比增长12.98%。净利润22.82亿元，同比增长21.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604223714119581.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604223714119581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600276","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629086542","title":"智通AH统计|4月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2629086542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629086542?lang=zh_cn&edition=full","pubTime":"2026-04-21 16:15","pubTimestamp":1776759306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月21日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为592.31%、329.12%、296.34%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-27.15%、-16.81%、-6.99%。其中东北电气、胜宏科技、长飞光纤光缆的偏离值位居前三，分别为69.47%、25.83%、23.66%；另外，金风科技、晨鸣纸业、绿色动力环保的偏离值位居后三，分别为-30.15%、-23.59%、-22.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00525","03908","01276","02338","00916","02359","00553","399300","HK0000252160.HKD","LU0128522157.USD","81211","LU0672654166.SGD","06865","01812","00317","02068","002594","00638","02218","02208","01108","02691","BK1140","BYDDY","159982","03143","LU1244550577.SGD","01033","06031","03968","02701","02603","01211","03678","03750","HYDD.SI","00895","00187","00300","01057","02899","01330","03986","00042","EWH","01349","06166","02476","06869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628479357","title":"恒瑞医药(01276)：HRS9531注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2628479357","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628479357?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:32","pubTimestamp":1776684735,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药 发布公告，近日，江苏恒瑞医药股份有限公司子公司福建盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS9531注射液的《药物临床试验批准通知书》，将于近期开展临床试验。HRS9531注射液是以HRS9531为主要活性成分，具有全球自主知识产权的新型靶向抑胃肽受体和胰高血糖素样肽-1受体的双激动剂，其用于成人长期体重管理的上市申请已于2025年9月获国家药监局受理。截至目前，HRS9531相关项目累计研发投入约6.32亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997245094.SGD","LU0405327494.USD","LU2543165471.USD","LU1328615791.USD","LU2289578879.USD","LU1023057109.AUD","LU2097828557.USD","LU0359201885.HKD","BK0183","LU1064130708.USD","BK1191","LU1255011170.USD","LU2580892789.USD","BK0188","LU2097828474.EUR","LU1655091616.SGD","BK0239","LU2097828714.EUR","LU2488822045.USD","LU1781817850.SGD","LU1820825898.SGD","LU0359201612.USD","LU2097828631.EUR","LU0359202008.SGD","LU2097828805.USD","BK0012","BK0028","BK0196","LU1997244956.HKD","LU2328871848.SGD","600276","LU1146622755.USD","LU2148510915.USD","01276","LU2495084118.USD","LU1064131003.USD","LU1580142542.USD","BK0060","LU1997245177.USD","LU0405327148.USD","LU1969619763.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628982748","title":"智通AH统计|4月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2628982748","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628982748?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:15","pubTimestamp":1776672905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月20日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为592.31%、325.57%、296.09%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-26.26%、-17.85%、-6.54%。其中东北电气、长飞光纤光缆、吉宏股份的偏离值位居前三，分别为75.24%、26.93%、23.68%；另外，金风科技、晨鸣纸业、绿色动力环保的偏离值位居后三，分别为-31.49%、-24.69%、-20.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0979878070.USD","01276","01330","01108","00553","00916","02603","02701","00895","00638","06865","HYDD.SI","06031","06869","01349","01812","02068","03908","LU0708995153.HKD","02208","159982","03750","LU0287142896.SGD","02359","01057","00187","01033","81211","LU1328277881.USD","03986","01989","03968","01618","00042","399300","03678","02899","06613","BYDDY","00317","02218","002594","03143","LU1868838027.USD","EWH","03268","01211","00300","02338"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628679211","title":"恒瑞医药将于5月27日派发末期股息每10股2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628679211","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628679211?lang=zh_cn&edition=full","pubTime":"2026-04-20 08:56","pubTimestamp":1776646560,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　恒瑞医药（01276）发布公告，该公司将于2026年5月27日派发末期股息每10股2元人民币。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-20/doc-inhvayqk0731739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997245094.SGD","LU0405327494.USD","LU2543165471.USD","LU1328615791.USD","LU2289578879.USD","LU1023057109.AUD","LU2097828557.USD","LU0359201885.HKD","BK4585","BK0183","LU1064130708.USD","BK1191","LU1255011170.USD","LU2580892789.USD","BK0188","LU2097828474.EUR","LU1655091616.SGD","BK0239","LU2097828714.EUR","LU2488822045.USD","LU1781817850.SGD","LU1820825898.SGD","LU0359201612.USD","LU2097828631.EUR","VIG","LU0359202008.SGD","LU2097828805.USD","BK0012","BK0028","BK0196","LU1997244956.HKD","LU2328871848.SGD","BK4588","600276","LU1146622755.USD","LU2148510915.USD","01276","LU2495084118.USD","LU1064131003.USD","LU1580142542.USD","BK0060","LU1997245177.USD","LU0405327148.USD","LU1969619763.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628766952","title":"减肥药企业Kailera纳斯达克上市：市值31亿美元 恒瑞医药成大赢家","url":"https://stock-news.laohu8.com/highlight/detail?id=2628766952","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628766952?lang=zh_cn&edition=full","pubTime":"2026-04-19 15:45","pubTimestamp":1776584754,"startTime":"0","endTime":"0","summary":"减肥药企业Kailera Therapeutics(股票代码：“KLRA”）日前在美国纳斯达克上市，发行价为16美元，发行3906万股，募资总额为6.24亿美元。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391221034231146037652788.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391221034231146037652788.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33340/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IYW","QLD","QID","600276","LU1255011170.USD","LU2289578879.USD","LU1969619763.USD","LU2543165471.USD","LU2580892789.USD","QDTE","QQQE","MNQmain","LU1997245177.USD","LU1781817850.SGD","QQQJ","BK1191","BK0028","KLRA","LU0359201885.HKD","LU1328615791.USD","BK4007","LU0359201612.USD","LU1997244956.HKD","BK0188","LU2328871848.SGD","QQQY","LU1146622755.USD","LU2580892862.HKD","QQQ","QQQM","LU2097828557.USD","BK0012","LU2097828631.EUR","BK0239","LU2097828474.EUR","ONEQ","QYLG","TQQQ","LU2488822045.USD","GPIQ","BK1147","LU1655091616.SGD","LU1023057109.AUD","LU1997245094.SGD","NQmain","BK0060","PSQ","NVIW.SI","LU2097828714.EUR","JEPQ","LU2495084118.USD","LU2148510915.USD","LU1064130708.USD","LU0405327494.USD","BK0196","LU2097828805.USD","LU1064131003.USD","LU1580142542.USD","SQQQ","LU0405327148.USD","QQQA","FTEC","TQQY","LU0359202008.SGD","01276","BK0183","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198794886","title":"恒瑞医药将于2026年05月27日派发末期股息每股0.23港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198794886","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198794886?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:51","pubTimestamp":1776433898,"startTime":"0","endTime":"0","summary":"恒瑞医药(01276)\n根据公司最新公告，董事会批准就截至2025年12月31日止年度派发末期股息，每10股派发2.2828港元，折合每股约0.23港元（四舍五入后）。股东批准日期为2026年4月16日，除净日定于2026年4月29日，股东如欲符合收取股息的资格，须于2026年4月30日16:30前递交过户登记文件。公司将于2026年5月4日至2026年5月11日暂停办理股份过户登记，5月11日为记录日期，并预计于2026年5月27日派发股息。\n公告同时更新了派息金额、公司预设派发货币、汇率及代扣所得税信息等。不同类型股东适用的代扣税率最高可达20%，具体以公司公告及相关税务法规为准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628542204","title":"恒瑞医药(01276)将于5月27日派发末期股息每10股2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628542204","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628542204?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:36","pubTimestamp":1776432977,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，由于2025年利润分派方案已于股东会获股东批准，董事会欣然宣布，向全体股东派发现金股息每10股人民币2元(含税)(2025年末期股息)。 2025年末期股息将派付予于2026年5月11日(星期一)(记录日期)名列本公司H股股东名册的H股股东。2025年末期股息预期于2026年5月27日(星期三)向H股股东派发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0359201885.HKD","LU2097828805.USD","LU1255011170.USD","LU2148510915.USD","600276","01276","LU2097828631.EUR","LU1969619763.USD","LU1064131003.USD","BK0183","BK4585","BK1191","LU2289578879.USD","LU1997245094.SGD","BK0060","LU2580892789.USD","LU1820825898.SGD","LU0405327148.USD","LU1781817850.SGD","LU2097828474.EUR","LU1146622755.USD","LU2495084118.USD","LU2580892862.HKD","BK0028","LU1328615791.USD","LU1580142542.USD","LU2097828557.USD","BK0188","LU1655091616.SGD","LU1997244956.HKD","LU2488822045.USD","LU2097828714.EUR","LU1997245177.USD","LU2543165471.USD","VIG","BK0012","BK0196","LU0359202008.SGD","LU1023057109.AUD","BK0239","LU1064130708.USD","LU2328871848.SGD","LU0405327494.USD","BK4588","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158890283","title":"恒瑞医药(01276)将于2026年05月27日派发末期股息每股0.20元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158890283","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158890283?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:35","pubTimestamp":1776432943,"startTime":"0","endTime":"0","summary":"恒瑞医药(01276)公告称，2025年利润分配方案已在2026年4月16日股东周年大会获得股东批准。公司将向于2026年5月11日（星期一）名列H股股东名册的股东派发2025年末期股息，每10股人民币2元（含税），折合每股人民币0.20元，并将于2026年5月27日（星期三）派付。H股股息以港元结算，每10股约2.28港元（含税），具体换算以大会前五个营业日人民币对港元平均基准汇率为准。公司回购账户所持股份不参与本次派息，若股份总数于记录日期前后发生变动，总派发金额将相应调整。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.0868},{"period":"3month","weight":-0.0601},{"period":"6month","weight":-0.1035},{"period":"1year","weight":0.563},{"period":"ytd","weight":-0.0337}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏恒瑞医药股份有限公司是一家主要从事药品的研发、生产和销售的中国公司。该公司专注于肿瘤领域，覆盖激酶抑制剂、抗体偶联药物（ADC）、肿瘤免疫、激素受体调控、脱氧核糖核酸（DNA）修复及表观遗传、支持治疗等研究领域。该公司的产品包括抗肿瘤、镇痛麻醉和造影剂，应用于自身免疫疾病、代谢性疾病、心血管疾病、感染疾病、呼吸系统疾病、血液疾病、疼痛管理、神经系统疾病、眼科、肾病等领域。该公司主要在国内外市场开展其业务。","exchange":"SEHK","name":"恒瑞医药","nameEN":"HENGRUI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,01276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}